Key result
Single-session transaxillary TAVI plus transseptal TMVR proves feasible and yields clinical improvement without transfemoral access.
Why the study?
Is a single-session fully percutaneous transaxillary TAVI combined with transseptal TMVR feasible in a patient with prohibitive surgical risk and contraindicated transfemoral access?
Case Report (n=1)
No
Is a single-session fully percutaneous transaxillary TAVI combined with transseptal TMVR feasible in a patient with prohibitive surgical risk and contraindicated transfemoral access?
Single-session percutaneous transaxillary TAVI combined with transseptal TMVR is a feasible and less invasive alternative to the transapical approach for patients requiring double-valve procedures who lack transfemoral arterial access.
Answers are grounded in this paper and cite their sources.
Supports feasibility of combined transaxillary TAVI-transseptal TMVR in prohibitive-risk patients; leaves open confirmation of safety in prospective series.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Sacha et al. (2026) conducted a case report in Severe native aortic stenosis and degenerated stenotic mitral bioprosthesis (n=1). Single-session percutaneous transaxillary TAVI combined with transseptal TMVR was evaluated on Procedural success and clinical improvement. Single-session percutaneous transaxillary TAVI combined with transseptal TMVR was feasible and resulted in marked clinical improvement in a patient without transfemoral access.
Synapse has enriched 10 related papers. Consider them for comparative context: